My watch list  


Systematic (IUPAC) name
CAS number 57982-77-1
ATC code L02AE01
PubChem 50225
DrugBank HMDB03170
Chemical data
Formula C62H90N16O15 
Mol. mass 1299.48 g/mol
Synonyms D-Ser(Tbu)6EA10LHRH
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 72 to 80 minutes
Excretion Renal
Therapeutic considerations
Pregnancy cat.


Legal status


Routes implant, intranasal

Buserelin is a Gonadotropin-releasing hormone agonist (GnRH agonist). By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, buserelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.

It is normally delivered via a nasal spray but is also available as an injection.

Buserelin acetate is marketed by Sanofi-Aventis under the brand name Suprefact.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Buserelin". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE